Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What are the Key Projections for the CAGR of the Peptide Antibiotics Market From 2025 to 2034?

In recent years, the market size for peptide antibiotics has seen a swift expansion. The figure will escalate from $5.25 billion in 2024 to $5.82 billion in 2025, marking a compound annual growth rate (CAGR) of 10.8%. The remarkable growth in the past was driven by factors such as the discovery and enhancement of peptide antibiotics, a surge in antibiotic resistance, an increase in occurrences of infectious diseases, advancements in peptide synthesis technologies, and expansion of the pharmaceutical sector.

The market size of peptide antibiotics is predicted to witness robust expansion in the coming years, escalating to $8.47 billion in 2029 with a compound annual growth rate (CAGR) of 9.8%. This growth in the projected period is attributed to the focus on the development of novel antibiotics, rising worldwide instances of antibiotic-resistant infections, the broadening of research and development in the field of antimicrobial peptides, alongside regulatory backing for new antibiotic approvals. Notable trends shaping this projection period include the search for antimicrobial peptides in natural sources, the employment of peptide antibiotics for animal health, emphasis on peptide engineering to enhance efficacy, the collaboration of peptide antibiotics, and incorporation of artificial intelligence and machine learning into the discovery of peptide antibiotics.

Which Major Market Drivers Are Expected to Boost the peptide antibiotics Market’s Growth Potential?

The escalation in the occurrence of numerous infectious diseases is predicted to stimulate the expansion of the peptide antibiotics market. Infectious diseases are conditions instigated by detrimental microorganisms such as bacteria, fungi, parasites, and more. The main factors that contribute to the escalation in infectious diseases include swift urbanization, climate changes, a heightened risk of disease emergence, among others, all of which boost the demand for peptide antibiotics. These antibiotics work by physically rupturing the cell membranes thereby enhancing their antibacterial action. For example, World Health Organization reports from May 2024 revealed that the instances of dengue in the America region had already exceeded seven million by April 2024. These figures are significantly higher than the 4.6 million cases reported in the entirety of 2023. Consequently, the escalation in infectious diseases is fueling the growth of the peptide antibiotics market.

Request Your Free Peptide Antibiotics Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=7780&type=smp

What Are the Key Industry Players Leading the Charge in the Peptide Antibiotics Market’s Growth?

Major companies operating in the peptide antibiotics market include:

• Eli Lilly and Company_x000D_

• GlaxoSmithKline plc_x000D_

• Novartis AG_x000D_

• Pfizer Inc._x000D_

• Merck & Co. Inc._x000D_

How Are Market Trends and Shifts Impacting the Growth Trajectory of the Peptide Antibiotics Market?

The emergence of strategic partnerships is becoming a significant trend in the peptide antibiotics market. Major companies in this sector are forming partnerships to expand their market reach and to utilize each other’s resources effectively. For example, in January 2022, Berkeley Lights, an American digital cell biology firm, forged a partnership with Aanika Biosciences. Through this partnership, Aanika will use Berkeley Lights’ efficient, high-throughput screening service to swiftly discover and refine functional antimicrobial peptides (AMPs) capable of eradicating harmful bacteria, specifically those responsible for foodborne disease outbreaks. Additionally, the Beacon Optofluidic Platform will be employed to identify peptides destructive to bacteria for the creation of a new antibacterial tag. This tag will be incorporated into their bacterial spore-based barcoding technology to bolster the security of the food supply chain. Aanika Biosciences is a biotechnology firm based in the United States.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/peptide-antibiotics-global-market-report

Which Primary Segments of the Peptide Antibiotics Market Are Driving Growth and Industry Transformations?

The peptide antibiotics market covered in this report is segmented –

1) By Type: Ribosomal Synthesized Peptide Antibiotics, Non-Ribosomal Synthesized Peptide Antibiotics

2) By Drugs: Daptomycin, Dalbavancin, Telavancin, Other Drugs

3) By Disease Outlook: Skin Infection, HABP Or VABP, Blood Stream Infection, Other Diseases

4) By Distribution Channel: Hospitals, Homecare, Specialty Clinics, Other Distribution Channels

Subsegments:

1) By Ribosomal Synthesized Peptide Antibiotics: Aminoglycosides, Macrolides, Tetracyclines, Lincosamides

2) By Non-Ribosomal Synthesized Peptide Antibiotics: Bacitracins, Vancomycin, Polymyxins, Cyclic Lipopeptides

What Regions Are Influencing the Dynamics of the Peptide Antibiotics Market?

North America was the largest region in the peptide antibiotics market in 2024. The regions covered in the peptide antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

How Is the Scope and Reach of the Peptide Antibiotics Market Defined?

Peptide antibiotics refer to antibiotics made up of peptides the physical rupture of cell membranes underpins the antibacterial activity. The peptide antibiotics are used to permeate bacterial membranes, collect within bacteria, and then interfere with bacterial functioning.

Browse Through More Similar Reports By The Business Research Company:

Anticoagulants Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/anticoagulant-global-market-report

Multivitamin Capsules And Tablets Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/multivitamin-capsules-and-tablets-global-market-report

Vitamin and Minerals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/vitamin-and-mineral-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: